Live News EQUITY FLASH L impact Oct 30, 2026, 01:12 PM UTC Guggenheim Keeps Tenet Healthcare at Buy, Cuts Target to $306 Guggenheim maintained its Buy rating and lowered its price target to $306 from $307. THC SquawkNews Desk